Literature DB >> 6465575

Reversal by nalbuphine of respiratory depression caused by fentanyl.

L Latasch, S Probst, R Dudziak.   

Abstract

In 60 ASA class I or II patients given intravenous fentanyl for elective operations in doses large enough to produce postoperative respiratory depression, the intravenous administration of 20 mg nalbuphine resulted in prompt reversal of respiratory depression without loss of analgesia.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6465575

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  13 in total

1.  Support for nalbuphine reversal of opioids: quantitative considerations.

Authors:  D B Gould
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

Review 2.  Agonist-antagonist opioids: theory and clinical practice.

Authors:  C Rosow
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

3.  Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine.

Authors:  C A Mills; J W Flacke; W E Flacke; B C Bloor; M D Liu
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

Review 4.  [Nalbuphine in pediatric anesthesia].

Authors:  A-M Schultz-Machata; K Becke; M Weiss
Journal:  Anaesthesist       Date:  2014-02       Impact factor: 1.041

5.  Female- and Intruder-induced Ultrasonic Vocalizations in C57BL/6J Mice as Proxy Indicators for Animal Wellbeing.

Authors:  Brian J Smith; Kate E P Bruner; Lon V Kendall
Journal:  Comp Med       Date:  2019-10-02       Impact factor: 0.982

6.  Side effects of nalbuphine while reversing opioid-induced respiratory depression: report of four cases.

Authors:  G A Blaise; M Nugent; J C McMichan; P A Durant
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

7.  Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride.

Authors:  Brian J Smith; Daniel J Wegenast; Ryan J Hansen; Ann M Hess; Lon V Kendall
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-11       Impact factor: 1.232

8.  Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain.

Authors:  K A Lehmann; B Tenbuhs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine.

Authors:  J P Penning; B Samson; A D Baxter
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063

10.  Which potent opioid? Important criteria for selection.

Authors:  J G Bovill
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.